‘groundbreaking’: first treatment targeting ‘super-gonorrhoea’ passes trial

‘groundbreaking’: first treatment targeting ‘super-gonorrhoea’ passes trial

Play all audios:

Loading...

* NEWS * 01 November 2023 Antibiotic could turn the tide on drug-resistant form of the infection — if it’s used wisely. By * Ewen Callaway * Ewen Callaway Medics could soon have a tool to


stem the rise of drug-resistant ‘super-gonorrhoea’. The first new antibiotic in decades for treating gonorrhoea has produced good results in a large-scale clinical trial, the non-profit


organization developing the drug announced today. ACCESS OPTIONS Access Nature and 54 other Nature Portfolio journals Get Nature+, our best-value online-access subscription $32.99 / 30 days


cancel any time Subscribe to this journal Receive 51 print issues and online access $199.00 per year only $3.90 per issue Rent or buy this article Prices vary by article type from$1.95


to$39.95 Prices may be subject to local taxes which are calculated during checkout ADDITIONAL ACCESS OPTIONS: _Nature_ 623, 236 (2023) _doi: https://doi.org/10.1038/d41586-023-03448-x_


REFERENCES SUBJECTS * Infection * Antibiotics LATEST ON: Antibiotics